featured
Relapse Outcomes Varies Among Injectable Immunomodulators for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Effectiveness of Glatiramer Acetate and Interferon Beta Formulations in Relapsing-Remitting Multiple Sclerosis
Mult. Scler. 2014 Dec 05;[EPub Ahead of Print], T Kalincik, V Jokubaitis, G Izquierdo, P Duquette, M Girard, P Grammond, A Lugaresi, C Oreja-Guevara, R Bergamaschi, R Hupperts, F Grand'Maison, E Pucci, V Van Pesch, C Boz, G Iuliano, R Fernandez-Bolanos, S Flechter, D Spitaleri, E Cristiano, F Verheul, J Lechner-Scott, MP Amato, JA Cabrera-Gomez, ML Saladino, M Slee, F Moore, O Gray, M Paine, M Barnett, E Havrdova, D Horakova, T Spelman, M Trojano, H ButzkuevenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.